Profile
Jan M.
van Tornout served as the Chief Medical Officer at Tyme Technologies, Inc. in 2021-2022.
He obtained his graduate degree from the University of Southern California, his undergraduate degree from Facultés Universitaires Notre-Dame de la Paix, and his graduate and doctorate degrees from Katholieke Universiteit Leuven Law School.
Former positions of Jan van Tornout
| Companies | Position | End |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 30/04/2022 |
Training of Jan van Tornout
| University of Southern California | Graduate Degree |
| Facultés Universitaires Notre-Dame de la Paix | Undergraduate Degree |
| Katholieke Universiteit Leuven Law School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Stock Market
- Insiders
- Jan van Tornout
